Monograph on the Potential Human Reproductive and ... - OEHHA
Monograph on the Potential Human Reproductive and ... - OEHHA
Monograph on the Potential Human Reproductive and ... - OEHHA
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
BISPHENOL A<br />
Table 82<br />
Summary of High Utility Developmental Toxicity Studies (Multiple Dose Levels)<br />
Bisphenol A dose level (mg/kg bw/day) Reference<br />
Model (treatment) Endpoint NOAEL LOAEL BMD 10 BMDL 10 BMD 1SD BMDL 1SD<br />
Rat<br />
Han–Wistar (drinking Male reproductive organ Z0.775–4.022 Cagen et al.<br />
water from before weights, sperm producti<strong>on</strong>, (high dose) (1999b)<br />
mating through testicular histopathology<br />
gestati<strong>on</strong> <strong>and</strong> lactati<strong>on</strong>)<br />
CD (gavage, 2-generati<strong>on</strong>s Prenatal or postnatal growth Z0.2 Ema et al.<br />
exposure including or survival, developmental (high dose) (2001)<br />
pre-<strong>and</strong> postnatal l<strong>and</strong>marks, anogenital distance,<br />
development periods) age of puberty, fertility,<br />
estrous cyclicity, or<br />
sperm counts<br />
Sprague–Dawley dam k Live fetuses/litter 300 1000 929 348 982 713 Kim et al.<br />
(gavage GD 1–20) (2001b)<br />
k Male body weight 100 300 456 339 694 497<br />
k Female body weight 300 1000 439 328 682 490<br />
k Ossificati<strong>on</strong> 300 1000<br />
Sprague–Dawley dam Volume of SDN-POA, age or Z320 Kw<strong>on</strong> et al.<br />
(gavage GD 11–PND 20) weight at vaginal opening (high dose) (2000)<br />
or first estrous, estrous cyclicity,<br />
mean lordosis intensity, prostate<br />
weight, or histopathology in<br />
ventral prostate, ovary, or uterus<br />
CD dams (gavage Implantati<strong>on</strong> sites, resorpti<strong>on</strong>s, Z640 Morrissey et al.<br />
GD 6–15) body weight, viability, sex ratio, (high dose) (1987)<br />
<strong>and</strong> malformati<strong>on</strong>s<br />
Sprague–Dawley m Uterine epi<strong>the</strong>lial cell nuclei 0.1 Schönfelder<br />
dam (gavage (low dose) et al. (2004)<br />
GD6–PND 21)<br />
m Uterine epi<strong>the</strong>lial nuclei with 0.1<br />
c<strong>on</strong>densed chromatin (low dose)<br />
m Uterine epi<strong>the</strong>lial cells 0.1<br />
with cavities (low dose)<br />
k ERb-positive cells in 0.1<br />
uterine tissue (low dose)<br />
kThickness of uterine 0.1 50<br />
luminal epi<strong>the</strong>lium<br />
m ERa-positive cells in 0.1 50<br />
uterine epi<strong>the</strong>lium<br />
Wistar-derived Delayed vaginal opening 0.1 50 68 51 35 16 Tinwell et al.<br />
Alderley–Park (2002)<br />
dams (gavage GD 6–21)<br />
k Sperm count/testis 0.1 50 55 30 57 31<br />
k Sperm count/g testis 0.1 50 81 41 68 34<br />
k Daily sperm count/testis 0.1 50 56 31 59 31<br />
k Daily sperm count/g testis 0.1 50 83 42 70 34<br />
Sprague–Dawley (dietary, Live F1 pups/litter 47.5 475 268 192 559 394 Tyl et al.<br />
multiple generati<strong>on</strong>s (2000b, 2002b)<br />
with exposure during<br />
pre-<strong>and</strong> post natal<br />
development)<br />
Live F2 pups/litter 47.5 475 422 152 459 294<br />
Live F3 pups/litter 47.5 475 236 174 376 286<br />
F1 body weight, PND 4 47.5 475 406 283 561 400<br />
F1, F2, or F2 body weight, PND 7 47.5 475 217–328 183–257 265–410 218–313<br />
F1, F2, or F2 body weight, PND 14 47.5 475 183–243 163–209 177–227 153–191<br />
F1, F2, or F2 body weight, PND 21 47.5 475 208–252 166–226 223–267 175–220<br />
m Age at F1 vaginal opening 47.5 475 394 343 206 176<br />
m Age at F2 vaginal opening 47.5 475 404 336 277 228<br />
m Age at F3 vaginal opening 47.5 475 471 401 396 203<br />
m Age at F1 preputial separati<strong>on</strong> 4.75 47.5 466 411 188 163<br />
m Age at F2 preputial separati<strong>on</strong> 47.5 475 300 255 241 203<br />
m Age at F3 preputial separati<strong>on</strong> 47.5 475 547 473 222 189<br />
Mating, fertility, pregnancy, or Z475<br />
gestati<strong>on</strong>al indices; (high dose)<br />
precoital interval,<br />
postimplantati<strong>on</strong> loss,<br />
estrous cyclicity,<br />
<strong>and</strong> reproductive<br />
organ histopathology;<br />
sperm count, morphology<br />
or motility;<br />
Birth Defects Research (Part B) 83:157–395, 2008<br />
321